EYEGOOD OPHTHALMIC Completed a $40 Million Series B Financing, CEC Capital Served as the Exclusive Financial Advisor

EYEGOOD OPHTHALMIC, a leading Chinese ophthalmic hospital chain, announced that it had completed a $40 million Series B financing led by CDH Investments. The Company completed its Series A financing with investment from Orbimed in 2015.

CEC Capital served as the Exclusive Financial Advisor to EYEGOOD OPHTHALMIC.